Full video transcriptClick to expand
Auto-generated transcript of @blackdosedaily's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Flex up.
- 0:01Catch up.
- 0:02Big mans.
- 0:03For one.
- 0:04Flex up.
- 0:05Big mans.
- 0:06For one.
- 0:07Flex up.
- 0:08Big mans.
- 0:09For one.
- 0:10Flex up.
- 0:11Big mans.
- 0:12For one.
- 0:13Flex up.
- 0:14Big mans.
- 0:15For one.
5-Amino-1MQ and NAD+ metabolism: what the research actually shows
Quick answer
5-Amino-1MQ is a small-molecule NNMT inhibitor studied in rodent models for potential effects on adipose tissue metabolism and NAD+ precursor availability, with the most-cited work being Neelakantan et al. (2019, Journal of Medicinal Chemistry). No human clinical trials have been published, and the compound is not FDA-approved or cleared for therapeutic use. Any human use occurs entirely outside a regulated clinical framework, with no established safety profile or dosing evidence in people.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For 5-Amino-1MQ and NAD+ metabolism: what the research actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "5-Amino-1MQ and NAD+ metabolism: what the research actually shows" from Shar•B𝐥𝐚𝐜𝐤D𝐨𝐬𝐞D𝐚𝐢𝐥𝐲. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: 5-Amino-1MQ is a small-molecule NNMT inhibitor studied in rodent models for potential effects on adipose tissue metabolism and NAD+ precursor availability, with the most-cited work being Neelakantan et al.
The reason this review is not generic is the source wording and the canonical claim label "peptides 5 amino 1mq is gaining attention in research for its potenti." In this clip, the useful excerpt is: "Flex up." That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
5-Amino-1MQ is a small-molecule NNMT inhibitor studied in rodent models for potential effects on adipose tissue metabolism and NAD+ precursor availability, with the most-cited work being Neelakantan et al.
FormBlends verdict
NAD+ Peptide Complex safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- 5-Amino-1MQ is a small-molecule NNMT inhibitor studied in rodent models for potential effects on adipose tissue metabolism and NAD+ precursor availability, with the most-cited work being Neelakantan et al. (2019, Journal of Medicinal Chemistry). No human clinical trials have been published, and the compound is not FDA-approved or cleared for therapeutic use. Any human use occurs entirely outside a regulated clinical framework, with no established safety profile or dosing evidence in people.
- The single most-cited study on 5-Amino-1MQ (Neelakantan et al., 2019, Journal of Medicinal Chemistry) involved mice, not humans, and showed fat mass reduction through NNMT inhibition.
- As of mid-2025, zero published Phase 1 or Phase 2 human clinical trials exist for 5-Amino-1MQ.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- The single most-cited study on 5-Amino-1MQ (Neelakantan et al., 2019, Journal of Medicinal Chemistry) involved mice, not humans, and showed fat mass reduction through NNMT inhibition.
- As of mid-2025, zero published Phase 1 or Phase 2 human clinical trials exist for 5-Amino-1MQ.
- NNMT is a real enzyme with a real role in NAD+ precursor metabolism, but inhibiting it systemically carries unknown off-target risks in humans.
- 5-Amino-1MQ is sold as a research chemical in most markets, meaning no regulatory body verifies purity, potency, or safety of available products.
- The creator's actual spoken transcript contains no scientific claims at all; all health framing comes from the caption only.
- Anti-aging hashtags attached to this compound have no specific research basis; no longevity study on 5-Amino-1MQ exists in any species.
- NAD+ pathway involvement does not automatically translate to measurable energy or metabolic benefits in humans without clinical trial confirmation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @blackdosedaily actually say?
Honestly? Not much about 5-Amino-1MQ at all. The transcript is a repeated loop of "Flex up. Big mans. For one." That's it. The scientific claims about NAD+ metabolism, mitochondrial function, and anti-aging all appear in the caption only, not in any spoken content. So there's nothing to quote from the creator directly, because the creator didn't actually explain anything. The video's caption does the heavy lifting, and even that stops mid-sentence. We're fact-checking a caption fragment and a hashtag pile.
This matters because the caption frames 5-Amino-1MQ as a compound with "potential role in NAD+ metabolism, mitochondrial function, and cellular energy support." Those are real research areas. But presenting them in a TikTok caption with no actual explanation, no caveats, and no acknowledgment that human data is extremely limited is a problem worth naming.
Does the science back this up?
There is some real preclinical research on 5-Amino-1MQ, but calling it "gaining attention" oversells a very thin body of work. Most of what exists comes from animal models, and the mechanism being studied is inhibition of an enzyme called NNMT (nicotinamide N-methyltransferase).
NNMT regulates how the body processes NAD+ precursors, and elevated NNMT activity has been linked to obesity and metabolic dysfunction in rodent studies. Neelakantan et al. (2019, Journal of Medicinal Chemistry) showed that 5-Amino-1MQ inhibited NNMT in mice and reduced fat mass without dietary changes. That's the study most promoters of this compound point to. It's one mouse study. Hong et al. (2015, Nature Chemical Biology) provides supporting context on NNMT's role in adipose tissue metabolism, but again, these are not human trials.
There are no published Phase 1 or Phase 2 human clinical trials on 5-Amino-1MQ as of mid-2025. The compound is not FDA-approved. Claiming it supports "cellular energy" in humans based on rodent NNMT inhibition data is a stretch that the current evidence doesn't justify.
What did they get wrong (or right)?
The caption gets the mechanism direction roughly right. NNMT does interact with NAD+ metabolism, and 5-Amino-1MQ does appear to inhibit it in animal models. That part isn't fabricated. Credit where it's due.
What's wrong is the framing. Phrases like "researchers are exploring" and "gaining attention" make this sound like a developing field with momentum. In reality, 5-Amino-1MQ sits in a very early, very narrow research pocket. The jump from "mice lost fat mass in one study" to "cellular energy support" for human consumers is a significant leap that the caption doesn't flag as speculative.
The hashtag "antiagingscience" is the most problematic element. There is no published research specifically linking 5-Amino-1MQ to longevity outcomes in any species. Connecting NNMT inhibition to anti-aging requires several inferential steps that researchers themselves haven't validated. Slapping an anti-aging hashtag on it isn't science communication. It's marketing dressed in lab language.
What should you actually know?
If you're seeing 5-Amino-1MQ promoted on social media, you should know a few things before taking any action. First, it is not a regulated therapeutic. It is sold as a research chemical in most jurisdictions, which means quality control, dosing accuracy, and purity are not guaranteed by any regulatory body.
Second, NNMT inhibition is a legitimate research target for metabolic disease, but inhibiting an enzyme that broadly regulates methylation reactions carries theoretical risks that haven't been studied in humans. Off-target effects are unknown. Long-term safety data doesn't exist.
Third, the NAD+ angle is real biology, but it's also one of the most commercially exploited pathways in the wellness space right now. Not every compound that touches NAD+ metabolism delivers meaningful NAD+ benefits in practice. The mechanistic story sounds clean in a caption. The human biology is considerably more complicated.
If metabolic health or body composition is your actual goal, there are interventions with actual human trial data behind them. A conversation with a licensed clinician who understands the current research is a better starting point than a TikTok caption that ends mid-sentence.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Shar•B𝐥𝐚𝐜𝐤D𝐨𝐬𝐞D𝐚𝐢𝐥𝐲 · TikTok creator
4.3K views on this video
🧬 5-Amino-1MQ is gaining attention in research for its potential role in NAD+ metabolism, mitochondrial function, and cellular energy support. 🔬 With interest in anti-aging, fat tissue focus, and metabolic pathways, researchers are exploring how this compound could impact health at the cellular level. ⚠️ This is not medical advice. Research peptides are for research purposes only. #5Amino1MQ #PeptideResearch #NADMetabolism #CellularEnergy #AntiAgingScience
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the single most-cited study on 5-amino-1mq (neelakantan et al., 2019,?
The single most-cited study on 5-Amino-1MQ (Neelakantan et al., 2019, Journal of Medicinal Chemistry) involved mice, not humans, and showed fat mass reduction through NNMT inhibition.
What does the video say about as of mid-2025, zero published phase 1?
As of mid-2025, zero published Phase 1 or Phase 2 human clinical trials exist for 5-Amino-1MQ.
What does the video say about nnmt?
NNMT is a real enzyme with a real role in NAD+ precursor metabolism, but inhibiting it systemically carries unknown off-target risks in humans.
What does the video say about 5-amino-1mq?
5-Amino-1MQ is sold as a research chemical in most markets, meaning no regulatory body verifies purity, potency, or safety of available products.
What does the video say about the creator's actual spoken transcript contains no scientific claims at?
The creator's actual spoken transcript contains no scientific claims at all; all health framing comes from the caption only.
What does the video say about anti-aging hashtags attached to this compound have no specific research?
Anti-aging hashtags attached to this compound have no specific research basis; no longevity study on 5-Amino-1MQ exists in any species.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Shar•B𝐥𝐚𝐜𝐤D𝐨𝐬𝐞D𝐚𝐢𝐥𝐲, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.